Myrbetriq ER 50 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FC8R4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,201
Award facts
- Contract value 100% obligated
- $23,200.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $23,200.89. This firm fixed-price delivery order, with an ultimate completion date of June 13, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The award falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare programs.
This delivery order exemplifies AmerisourceBergen's role as a critical federal medical procurement vendor, supplying pharmaceuticals and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract demonstrates the vendor's capability to fulfill diverse medical product requirements through open competition, as evidenced by its extensive portfolio of federal awards covering medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The rapid completion timeline reflects the operational nature of delivery orders executing against the established IDC framework.
Quick answers
Who was awarded contract SPE2DB25FC8R4?
SPE2DB25FC8R4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 12, 2025.
How much is contract SPE2DB25FC8R4 worth?
The government has obligated $23,201 on SPE2DB25FC8R4.
Is contract SPE2DB25FC8R4 an order under another contract?
Yes. SPE2DB25FC8R4 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FC8R4 competed?
The extent of competition for SPE2DB25FC8R4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award